3639 results for «250»
3639 results
Complex STEMI cases: Dextrocardia, thrombosis and coronary aneurysms
05 Oct 2024 – From AICT-AsiaPCR 2024
Prepare to be captivated by a collection of intriguing STEMI cases, curated from the AICT-AsiaPCR 2024 submissions. From a left main PCI in a patient with dextrocardia to a challenging case of primary PCI in an aneurysmal coronary artery, this session promises to push the boundaries...
Navigating complex left main and multivessel coronary disease
05 Oct 2024 – From AICT-AsiaPCR 2024
Delve into the complexities of left main and multivessel disease in this captivating session, featuring selected AICT-AsiaPCR 2024 clinical case submissions. Witness expert cardiologists navigate intricate scenarios, from primary angioplasty of the left main with cardiogenic shock to the management of a complex left main bifurcation...
AICT-AsiaPCR 2025 Awards ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Awards ceremony celebrates outstanding achievements and innovations in the field of interventional cardiology. This event recognizes the contributions of clinicians and researchers who have advanced cardiovascular care and highlights excellence across various domains within the specialty.
AICT-AsiaPCR 2025 Opening ceremony
10 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Opening Ceremony marked the commencement of the conference's comprehensive program, setting the stage for cutting-edge discussions and advancements in interventional cardiology across the Asia-Pacific region.
AICT-AsiaPCR 2025 Closing ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Closing ceremony marks the culmination of a comprehensive cardiology conference, reflecting on key scientific advancements, collaborative achievements, and the shared commitment to advancing cardiovascular medicine and patient care.
Discover what went on at PCR Imaging Valves Madrid 2023
Evolution of Imaging
18 Jul 2017
Ever since the creation of the X-ray machine by Wilhelm Conrad Röntgen, the imaging technologies and tools has evolved and gained a crucial role in the treatment of cardiovascular diseases. Learn more about the importance of imaging in interventional cardiology.
A new percutaneous technique for effective vascular access site closure in patients undergoing TAVI and thoraco-abdominal aortic aneurysm repairs
09 Jan 2019
Results of the PASTE study
Authors :
A stuck Rota burr in a "flintstone" coronary artery
18 Dec 2023
Step by Step video on how to deal with a stuck Rota burr with the same arterial access. Nice example of Kokeshi phenomenon.
Author
Author
Case report: Renal denervation using ultrasound energy (uRDN)
23 Oct 2024
In this case report, we examine an advanced technique for renal denervation (RDN)—ultrasound energy—employed to manage severe hypertension in patients with complex medical histories.
Author
Case report: Renal denervation using radiofrequency energy (rRDN)
20 Sep 2024
In this case report, we examine an advanced technique for renal denervation (RDN)—radiofrequency energy—employed to manage severe hypertension in patients with complex medical histories.
Author
The impact of COVID-19 pandemic on interventional cardiologists in training
23 Oct 2020
In collaboration with EuroIntervention Journal
The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...
The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?
07 Apr 2024
Charles Fauvel provides his take on the RELIEVE-HF study outcomes presented by Gregg W. Stone at ACC.24 in Atlanta.
Author
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data
19 Sep 2022
Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.
Author
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
03 Sep 2025
Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.
Author
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
